Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Phase 2 Results of the iR 2 Regimen (Ibrutinib, Lenalidomide, and Rituximab) in Patients with Relapsed/Refractory (R/R) Non-Germinal Center B Cell-like (Non-GCB) Diffuse Large B-Cell Lymphoma (DLBCL)

Blood (2019) 134 (Supplement_1): 761.

https://doi.org/10.1182/blood-2019-121521

Published: 2019

Journal Articles

The iR 2 Regimen(Ibrutinib, Lenalidomide, and Rituximab) Is Active with a Manageable Safety Profile in Patients with Relapsed/Refractory Non-Germinal Center-like Diffuse Large B-Cell Lymphoma

Blood (2018) 132 (Supplement 1): 402.

https://doi.org/10.1182/blood-2018-99-111163

Published: 2018

Journal Articles

Evaluation of Endocrine Complications in Beta-Thalassemia Intermedia Patients: A Cross Sectional Multi-Center Study

Blood (2018) 132 (Supplement 1): 2343.

https://doi.org/10.1182/blood-2018-99-110903

Published: 2018

Journal Articles

Transfusion Practices Among Hematology/Oncology Healthcare Professionals

Majd T Ghanim, MD, Jennifer H Voeks, PhD, Julie Kanter, MD

Blood (2018) 132 (Supplement 1): 2552.

https://doi.org/10.1182/blood-2018-99-111925

Published: 2018

Journal Articles

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Luciano Baronciani, PhD, Flora Peyvandi, MD PhD, Anne Goodeve, PhD, Reinhard Schneppenheim, MDPhD, Zahra Badiee, Mohammad-Reza Baghaipour, Javier Battle, Erik Berntorp, MD PhD, Imre Bodó, MD PhD, Ulrich Budde, MD, Andrea Cairo, PhD, Giancarlo Castaman, Laura Crookes, Jeroen C.J. Eikenboom, MD, Peyman Eshghi, MD, Cosimo Ettorre, MD, Jenny Goudemand, MD PhD, Wolf Hassenpflug, Charles Richard Morris Hay, MDFRCP,FRCPath, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank W.G. Leebeek, MD PhD, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, MD, Maria Gabriella Mazzucconi, MD, Massimo Morfini, MD, Nikolas Nikšić, Johannes Oldenburg, Florian Oyen, Rafael Parra Lòpez, Ian Peake, PhD, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Sayed Omid Reza Zekavat, MD, Eva M.K. Zetterberg, MD PhD, Augusto B Federici, MD

Blood (2018) 132 (Supplement 1): 1184.

https://doi.org/10.1182/blood-2018-99-114702

Published: 2018

Journal Articles

First Report of α-Thalassemia Genotypes from Transcaucasia

Gunay Aliyeva, Chingiz Asadov, Tahira Mammadova, Zaur Mammadbayov, Eldar Abdulalimov, Surmaya Gafarova

Blood (2018) 132 (Supplement 1): 4899.

https://doi.org/10.1182/blood-2018-99-110285

Published: 2018

Journal Articles

Leukocyte Adhesion Deficiency-I (LAD-I): A Comprehensive Review of Published Cases

Sanchali Kasbekar, PharmD, Juan Bueren, PhD, Adrian J Thrasher, MD PhD FMedSci, Donald B Kohn, MD, Julian Sevilla, MD PhD, Jonathan D Schwartz, MD, Elena Almarza, PhD

Blood (2017) 130 (Supplement 1): 4821.

https://doi.org/10.1182/blood.V130.Suppl_1.4821.4821

Published: 2017

Journal Articles

Comparative Studies on a Branded Recombinant Factor VIIa and Its Generic Version to Demonstrate Bioequivalence

Nasir Sadeghi, Zafar Siddiqui, Omer Iqbal, Schuharazad Abro, Debra Hoppensteadt, PhD, Michael Mosier, Jeanine Walenga, Jawed Fareed, PhD, Ahmed Kouta

Blood (2017) 130 (Supplement 1): 4868.

https://doi.org/10.1182/blood.V130.Suppl_1.4868.4868

Published: 2017

Journal Articles

A Large Case Series on Surgical Outcomes in Congenital FXIII Deficiency Patients in Iran

Mehran Karimi, MD, Majid Naderi, MD, Sezaneh Haghpanah, Ghasem Miri-Aliabad, MD, Hakimeh Tavoosi, Flora Peyvandi

Blood (2017) 130 (Supplement 1): 4874.

https://doi.org/10.1182/blood.V130.Suppl_1.4874.4874

Published: 2017

Journal Articles

Treatment of Elderly and Relapsed/Refractory AML Patient Using Cytosar and Arsenic Trioxide

Mohammad Eslamijouybari, MDMD, Ardeshir Ghavamzadeh, MD, Kamran Alimoghaddam, MD, Mohammad Vaezi, Marjan Yaghmaie, PhD

Blood (2017) 130 (Supplement 1): 5055.

https://doi.org/10.1182/blood.V130.Suppl_1.5055.5055

Published: 2017

Journal Articles

Treatment Outcome of North American Patients with Adult T-Cell Leukemia/Lymphoma: Princess Margaret Cancer Centre Experience

Mary Salib, MD, Melania Pintilie, MSc, Rick Wang, John Kuruvilla, MD, Vishal Kukreti, MD, Michael Crump, MD

Blood (2016) 128 (22): 3010.

https://doi.org/10.1182/blood.V128.22.3010.3010

Published: 2016

Journal Articles

A Large-Scale Prospective Cohort Study on Factor XIII Deficiency in Southeast of Iran

Majid Naderi, MD, Akbar Dorgalaleh, PhD, Eshghi Peyman, MD, Fatemeh Malek, MD, Mehran Karimi, MD

Blood (2016) 128 (22): 209.

https://doi.org/10.1182/blood.V128.22.209.209

Published: 2016

Journal Articles

Response to Imatinib in e13a2 Versus e14a2 BCR-ABL Fusion Transcripts in Chronic Myeloid Leukemia Saudi Patients

Wafa M. Elbjeirami, PhD, Amal S. Alabdulwahab, MD, Hussein G. ELSayed, MD, Nermeen Adel Abdelghaffer, MD, Noha Elnagdi, MD, Hanadi Al-Jedani, MD, Nahla Abd Allatif, MD, Abdulaziz Al Shaikh, MD, Faisal Al-Allaf, PhD

Blood (2016) 128 (22): 5453.

https://doi.org/10.1182/blood.V128.22.5453.5453

Published: 2016

Journal Articles

Prevalence of Discrepancy Between the Results of One-Stage and Chromogenic Factor VIII:C Assays in Iranian Patients with Mild / Moderate Hemophilia A

Minoo Ahmadinejad, MD, Fatemeh Vossough, Kataioon Karimi, MD, Mohammad Reza Tabatabaei, Sanaz Homayoun, Mehran Karimi, MD, Gholamreza Toogeh, MD

Blood (2016) 128 (22): 4982.

https://doi.org/10.1182/blood.V128.22.4982.4982

Published: 2016

Journal Articles

Correlation of Serum Ferritin Levels with Liver and Heart Mri T2 and Liver Iron Concentration in Beta Thalassemia Intermediate Patients: A Contemporary Issue

Mehran Karimi, MD, Fatemeh Amirmoezi, Sezaneh Haghpanah, MD MPH., Seyed pouria Ostad, Mehrzad Lotfi, Sepideh Sefidbakht, Shahed Rezaian

Blood (2016) 128 (22): 4829.

https://doi.org/10.1182/blood.V128.22.4829.4829

Published: 2016

Journal Articles

Bortezomib Consolidation after Nonmyeloablative Allogeneic Stem Cell Transplantation Leads to a High Incidence of Immunophenotypic Complete Response in Young and/or High-Risk Multiple Myeloma Patients

Richard LeBlanc, MD, Imran Ahmad, MD, Rafik Terra, PhD, Séverine Landais, PhD, Michael Sebag, MD PhD, Emilie Lemieux-Blanchard, MD, Nadia M. Bambace, MD, Lea Bernard, MD, Sandra Cohen, MD, Jean-Sebastien Delisle, MD PhD, Thomas Kiss, MD, Silvy Lachance, MD, Denis-Claude Roy, MD, Guy Sauvageau, MD PhD, Jean Roy, MD

Blood (2016) 128 (22): 2306.

https://doi.org/10.1182/blood.V128.22.2306.2306

Published: 2016

Journal Articles

Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease

Nancy Robitaille, MD, Yves D. Pastore, MD, Anne-Julie Landry, M.Sc, Catherine Latour, MD, Josée Lavoie, M.Sc, Geneviève Laflamme, M.Sc, Josée Perreault, PhD, Maryse St-Louis, PhD

Blood (2016) 128 (22): 2486.

https://doi.org/10.1182/blood.V128.22.2486.2486

Published: 2016

Journal Articles

Factors Impacting Quality of Life in Thalassemia Patients; Results from the Intercontinenthal Collaborative Study

Ali Amid, MD, Rebecca Leroux, BScN, Manuela Merelles-Pulcini, MSc, Saeed Yassobi, MD, Antoine N Saliba, MD, Richard Ward, MSc, MRCP, FRCPath, Mehran Karimi, MD, Ali T. Taher, MD PhD, Robert J Klaassen, MD, Melanie Kirby-Allen, MD

Blood (2016) 128 (22): 3633.

https://doi.org/10.1182/blood.V128.22.3633.3633

Published: 2016

Journal Articles

Tracking Effector T Cell Dynamics and Immune Inhibitory Receptors in Patients with Acute Myeloid Leukemia (AML)

Hanna A. Knaus, MD, Raúl Montiel-Esparza, MD, Joshua F. Zeidner, MD, Amanda Blackford, ScM, Christopher G. Kanakry, MD, Ante Vulic, MD, Mark J. Levis, MD PhD, Judith E. Karp, MD, Leo Luznik, MD, Ivana Gojo, MD

Blood (2015) 126 (23): 3849.

https://doi.org/10.1182/blood.V126.23.3849.3849

Published: 2015

Journal Articles

Quality of Life in Children with Rare Bleeding Disorders

Mehran Karimi, MD, Hassan Mohtadi, MD, Sezaneh Haghpanah, MD MPH., Mahboobeh Akbari, BS.

Blood (2015) 126 (23): 4698.

https://doi.org/10.1182/blood.V126.23.4698.4698

Published: 2015

NARROW

Phase 2 Results of the iR 2 Regimen (Ibrutinib, Lenalidomide, and Rituximab) in Patients with Relapsed/Refractory (R/R) Non-Germinal Center B Cell-like (Non-GCB) Diffuse Large B-Cell Lymphoma (DLBCL)

The iR 2 Regimen(Ibrutinib, Lenalidomide, and Rituximab) Is Active with a Manageable Safety Profile in Patients with Relapsed/Refractory Non-Germinal Center-like Diffuse Large B-Cell Lymphoma

Evaluation of Endocrine Complications in Beta-Thalassemia Intermedia Patients: A Cross Sectional Multi-Center Study

Transfusion Practices Among Hematology/Oncology Healthcare Professionals

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

First Report of α-Thalassemia Genotypes from Transcaucasia

Leukocyte Adhesion Deficiency-I (LAD-I): A Comprehensive Review of Published Cases

Comparative Studies on a Branded Recombinant Factor VIIa and Its Generic Version to Demonstrate Bioequivalence

A Large Case Series on Surgical Outcomes in Congenital FXIII Deficiency Patients in Iran

Treatment of Elderly and Relapsed/Refractory AML Patient Using Cytosar and Arsenic Trioxide

Treatment Outcome of North American Patients with Adult T-Cell Leukemia/Lymphoma: Princess Margaret Cancer Centre Experience

A Large-Scale Prospective Cohort Study on Factor XIII Deficiency in Southeast of Iran

Response to Imatinib in e13a2 Versus e14a2 BCR-ABL Fusion Transcripts in Chronic Myeloid Leukemia Saudi Patients

Prevalence of Discrepancy Between the Results of One-Stage and Chromogenic Factor VIII:C Assays in Iranian Patients with Mild / Moderate Hemophilia A

Correlation of Serum Ferritin Levels with Liver and Heart Mri T2 and Liver Iron Concentration in Beta Thalassemia Intermediate Patients: A Contemporary Issue

Bortezomib Consolidation after Nonmyeloablative Allogeneic Stem Cell Transplantation Leads to a High Incidence of Immunophenotypic Complete Response in Young and/or High-Risk Multiple Myeloma Patients

Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease

Factors Impacting Quality of Life in Thalassemia Patients; Results from the Intercontinenthal Collaborative Study

Tracking Effector T Cell Dynamics and Immune Inhibitory Receptors in Patients with Acute Myeloid Leukemia (AML)

Quality of Life in Children with Rare Bleeding Disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only